GeneOne Life Science, Inc. — Investor Relations & Filings
GeneOne Life Science, Inc. is a biopharmaceutical research and development company specializing in nucleic acid-based biomedicines. The company's core focus is on developing DNA and mRNA vaccines, particularly for emerging infectious diseases, leveraging its rapid development platforms. In therapeutics, GeneOne utilizes a proprietary DNA plasmid delivery technology to enable the expression of recombinant proteins and plasmid-encoded monoclonal antibodies (Plas-mAbs®). This non-viral vector approach is designed to offer a safer and more cost-effective alternative to traditional gene therapies and cell-line derived monoclonal antibody treatments for conditions such as cancers and autoimmune disorders. The company also develops immunomodulatory small molecule drugs. Through its subsidiary, GeneOne possesses cGMP-grade manufacturing capabilities for DNA plasmids, supporting its internal pipeline and contract manufacturing services.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 유상증자또는주식관련사채등의발행결과(자율공시) | 2026-05-07 | Korean | |
| [기재정정]타법인주식및출자증권취득결정 | 2026-04-30 | Korean | |
| [기재정정]유상증자결정(종속회사의주요경영사항) | 2026-04-30 | Korean | |
| [기재정정]의결권대리행사권유참고서류 | 2026-04-29 | Korean | |
| [기재정정]주주총회소집공고 | 2026-04-29 | Korean | |
| [기재정정]의결권대리행사권유참고서류 | 2026-04-29 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42619336 | 유상증자또는주식관련사채등의발행결과(자율공시) | 2026-05-07 | Korean | ||
| 39058075 | [기재정정]타법인주식및출자증권취득결정 | 2026-04-30 | Korean | ||
| 39057827 | [기재정정]유상증자결정(종속회사의주요경영사항) | 2026-04-30 | Korean | ||
| 38431935 | [기재정정]의결권대리행사권유참고서류 | 2026-04-29 | Korean | ||
| 38415264 | [기재정정]주주총회소집공고 | 2026-04-29 | Korean | ||
| 38415150 | [기재정정]의결권대리행사권유참고서류 | 2026-04-29 | Korean | ||
| 38258608 | [기재정정]주요사항보고서(전환사채권발행결정) | 2026-04-29 | Korean | ||
| 38258386 | [기재정정]주요사항보고서(감자결정) | 2026-04-29 | Korean | ||
| 37959274 | [기재정정]주주총회소집결의 | 2026-04-28 | Korean | ||
| 37712668 | [기재정정]주요사항보고서(자기전환사채매도결정) | 2026-04-28 | Korean | ||
| 34689946 | 주요사항보고서(자기전환사채매도결정) | 2026-04-20 | Korean | ||
| 34689719 | [기재정정]주요사항보고서(전환사채권발행결정) | 2026-04-20 | Korean | ||
| 34653557 | [기재정정]주요사항보고서(전환사채권발행결정) | 2026-04-17 | Korean | ||
| 34565030 | 주주총회소집공고 | 2026-04-15 | Korean | ||
| 34565020 | 의결권대리행사권유참고서류 | 2026-04-15 | Korean | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
GeneOne Life Science, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17719/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17719 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17719 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17719 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17719}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for GeneOne Life Science, Inc. (id: 17719)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.